Publications by authors named "Yuto Fujiki"

Claim this Profile
M
Minichromosome maintenance 4 is associated with poor survival and stemness of patients with pancreatic cancer.
Yuto Fujiki, Akira Ishikawa, Narutaka Katsuya, Yuki Shiwa, Takafumi Fukui

Med Mol Morphol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Severe acne with diffuse sclerosing osteomyelitis of the mandible: a unique presentation of synovitis, acne, pustulosis, hyperostosis and osteitis syndrome.
Shin Iinuma, Takahiro Kobayashi, Manabu Tsuji, Takahiro Abe, Yuto Fujiki

Eur J Dermatol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blue Nevus Associated With Acquired Dermal Melanocytosis on the Back.
Shin Iinuma, Takahiro Kobayashi, Yuto Fujiki

Cureus· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1/2a clinical trial in ALS with ropinirole, a drug candidate identified by iPSC drug discovery.
Satoru Morimoto, Shinichi Takahashi, Daisuke Ito, Yugaku Daté, Kensuke Okada, Yuto Fujiki

Cell Stem Cell· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protocadherin B9 Is Associated with Human Esophageal Squamous Cell Carcinoma Progression.
Yuto Fujiki, Akira Ishikawa, Shintaro Akabane, Shoichiro Mukai, Ryota Maruyama

Pathobiology· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overexpression of aldolase, fructose-bisphosphate C and its association with spheroid formation in colorectal cancer.
Ryota Maruyama, Yuma Nagaoka, Akira Ishikawa, Shintaro Akabane, Yuto Fujiki

Pathol Int· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I/IIa double blind single institute trial of low dose sirolimus for Pendred syndrome/DFNB4.
Masato Fujioka, Takumi Akiyama, Makoto Hosoya, Kayoko Kikuchi, Yuto Fujiki

Medicine (Baltimore)· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulation of insulin-like growth factor binding protein-1 and lipoprotein lipase by the aryl hydrocarbon receptor.
Keiichi Minami, Miki Nakajima, Yuto Fujiki, Miki Katoh, Frank J Gonzalez

J Toxicol Sci· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic polymorphisms of CYP2B6 affect the pharmacokinetics/pharmacodynamics of cyclophosphamide in Japanese cancer patients.
Miki Nakajima, Sayaka Komagata, Yuto Fujiki, Yoshihiro Kanada, Hiromichi Ebi

Pharmacogenet Genomics· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of paclitaxel in ovarian cancer patients and genetic polymorphisms of CYP2C8, CYP3A4, and MDR1.
Miki Nakajima, Yuto Fujiki, Satoru Kyo, Taro Kanaya, Mitsuhiro Nakamura

J Clin Pharmacol· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel polymorphism of human CYP2A6 gene CYP2A6*17 has an amino acid substitution (V365M) that decreases enzymatic activity in vitro and in vivo.
Tatsuki Fukami, Miki Nakajima, Ryoko Yoshida, Yuki Tsuchiya, Yuto Fujiki

Clin Pharmacol Ther· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of the aryl hydrocarbon receptor and Cyp1b1 in the antiestrogenic activity of 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Kei Takemoto, Miki Nakajima, Yuto Fujiki, Miki Katoh, Frank J Gonzalez

Arch Toxicol· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic polymorphisms of CYP2C8 in Japanese population.
Miki Nakajima, Yuto Fujiki, Kumiko Noda, Hiroki Ohtsuka, Hisashi Ohkuni

Drug Metab Dispos· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis